Artidis® is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. Artidis focuses its efforts on solid tumors to enhance responses to chemo, immuno, and cell therapies, driving precision in cancer care.
Products, services, technology
The platform integrates all types of clinical data to generate actionable treatment insights. Artidis measures cell & tissue stiffness and can be applied to any material/living tissue providing a broad range of R&D and clinical applications.
- https://www.artidis.com
- +41 61 633 29 95
- Send an email
- Marija Plodinec, CEO
Some insights
We measure the physics of cancer to improve patient outcomes by ensuring each patient receives the right treatment, the first time. We envision that our nanomechanical technology will unlock a new dimension of powerful insights to fuel unprecedented clinical advances and improve human health.
We are deeply committed to pioneering research innovations that can be meaningfully translated into clinical practice.
We are recruiting people who believe in the power of science and innovation to make a difference in patients' lives. We are looking for bold thinkers ready to take ownership in a dynamic, collaborative environment.
Doing hard work with friends. We are developing a machine which can diagnose cancer patients faster and get them the right medicine.
We expect the Swiss biotech ecosystem to connect brilliant minds and provide them with platforms for progress. It should bridge the private and public sectors, create visibility between these worlds, attract top talent, open up funding opportunities, and foster strong networking and collaboration.
Investors, R&D leaders in Life Sciences & Biotech, Academics in Mechanobiology
